ω-3 Polyunsaturated fatty acids-derived lipid metabolites on angiogenesis, inflammation and cancer

Prostaglandins and Other Lipid Mediators

Volumn 113-115, Issue , 2014, Pages 13-20

  Wang, Weicang ^a   Zhu, Julia ^a   Lyu, Fei ^a   Panigrahy, Dipak ^b   Ferrara, Katherine W ^c   Hammock, Bruce ^d   Zhang, Guodong ^a  

^a UNIVERSITY OF MASSACHUSETTS   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c University of California   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Cyclooxygenase; Cytochrome P450; Lipoxygenase; 3 polyunsaturated fatty acids

Indexed keywords

20 HYDROXYICOSATETRAENOIC ACID; ARACHIDONIC ACID; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITOR; CYTOCHROME P450; DOCOSAHEXAENOIC ACID; FISH OIL; ICOSANOID; ICOSAPENTAENOIC ACID; ICOSAPENTAENOIC ACID ETHYL ESTER; ICOSATETRAENOIC ACID; LINOLEIC ACID; LIPOXYGENASE; OMEGA 3 ACID ETHYL ESTER; OMEGA 3 FATTY ACID; OMEGA 6 FATTY ACID; PROSTAGLANDIN E RECEPTOR 2; PROSTAGLANDIN E2; PROSTAGLANDIN E3; PROSTAGLANDIN SYNTHASE; CYTOCHROME;

ANALGESIA; ANGIOGENESIS; ANTIANGIOGENIC ACTIVITY; ANTIINFLAMMATORY ACTIVITY; BIOLOGICAL ACTIVITY; BRAIN METASTASIS; CANCER INHIBITION; CANCER RISK; CELL PROLIFERATION; DIET SUPPLEMENTATION; DRUG MECHANISM; FAT INTAKE; HUMAN; HYPERTRIGLYCERIDEMIA; INFLAMMATION; LEUKEMIA; LIPID METABOLISM; METABOLITE; METASTASIS; METASTATIC MELANOMA; NEOPLASM; NONHUMAN; REVIEW; TUMOR GROWTH; VASODILATATION; ANIMAL; ENZYMOLOGY; METABOLISM; NEOVASCULARIZATION (PATHOLOGY); VASCULARIZATION;

ANIMALS; CYTOCHROMES; FATTY ACIDS, OMEGA-3; FATTY ACIDS, OMEGA-6; HUMANS; INFLAMMATION; LIPID METABOLISM; LIPOXYGENASES; NEOPLASMS; NEOVASCULARIZATION, PATHOLOGIC; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES;

EID: 84910003799     PISSN: 10988823     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.prostaglandins.2014.07.002     Document Type: Review

References (100)

1. T.J. Key, N.E. Allen, E.A. Spencer, and R.C. Travis The effect of diet on risk of cancer Lancet 360 9336 2002 861 868
2. S. Sasazuki, M. Inoue, and M. Iwasaki Intake of n-3 and n-6 polyunsaturated fatty acids and development of colorectal cancer by subsite: Japan Public Health Center-based prospective study Int J Cancer 129 7 2011 1718 1729
3. H.J. Murff, M.J. Shrubsole, and Q. Cai Dietary intake of PUFAs and colorectal polyp risk Am J Clin Nutr 95 3 2012 703 712
4. S. Kim, D.P. Sandler, J. Galanko, C. Martin, and R.S. Sandler Intake of polyunsaturated fatty acids and distal large bowel cancer risk in whites and African Americans Am J Epidemiol 171 9 2010 969 979
5. M.N. Hall, J.E. Chavarro, I.M. Lee, W.C. Willett, and J. Ma A 22-year prospective study of fish, n-3 fatty acid intake, and colorectal cancer risk in men Cancer Epidemiol Biomarkers Prev 17 5 2008 1136 1143
6. K. Almendingen, A.T. Hostmark, O. Fausa, A. Mosdol, L. Aabakken, and M.H. Vatn Familial adenomatous polyposis patients have high levels of arachidonic acid and docosahexaenoic acid and low levels of linoleic acid and alpha-linolenic acid in serum phospholipids Int J Cancer 120 3 2007 632 637
7. I. Schloss, M.S. Kidd, H.Y. Tichelaar, G.O. Young, and S.J. O'Keefe Dietary factors associated with a low risk of colon cancer in coloured west coast fishermen S Afr Med J 87 2 1997 152 158
8. G.K. Pot, A. Geelen, E.M. van Heijningen, C.L. Siezen, H.J. van Kranen, and E. Kampman Opposing associations of serum n-3 and n-6 polyunsaturated fatty acids with colorectal adenoma risk: an endoscopy-based case-control study Int J Cancer 123 8 2008 1974 1977
9. A. Wolk, S.C. Larsson, J.E. Johansson, and P. Ekman Long-term fatty fish consumption and renal cell carcinoma incidence in women JAMA 296 11 2006 1371 1376
10. T.M. Brasky, J.W. Lampe, J.D. Potter, R.E. Patterson, and E. White Specialty supplements and breast cancer risk in the VITamins And Lifestyle (VITAL) Cohort Cancer Epidemiol Biomarkers Prev 19 7 2010 1696 1708
11. V. Chajes, G. Torres-Mejia, and C. Biessy Omega-3 and omega-6 polyunsaturated fatty acid intakes and the risk of breast cancer in Mexican women: impact of obesity status Cancer Epidemiol Biomarkers Prev 21 2012 319 326
12. J. Wang, E. John, and S. Ingles 5-Lipoxygenase and 5-lipoxygenase-activating protein gene polymorphisms, dietary linoleic acid, and risk for breast cancer Cancer Epidemiol Biomarkers Prev 17 2008 2748 2754
13. A. Thiebaut, V. Chajes, and M. Gerber Dietary intakes of omega-6 and omega-3 polyunsaturated fatty acids and the risk of breast cancer Int J Cancer 124 2009 924 931
14. E. Sonestedt, U. Ericson, B. Gullberg, K. Skog, H. Olsson, and E. Wirfalt Do both heterocyclic amines and omega-6 polyunsaturated fatty acids contribute to the incidence of breast cancer in postmenopausal women of the Malmo diet and cancer cohort? Int J Cancer 123 2008 1637 1643
15. H. Murff, X. Shu, and H. Li Dietary polyunsaturated fatty acids and breast cancer risk in Chinese women: a prospective cohort study Int J Cancer 128 2011 1434 1441
16. M. Gago-Dominguez, J. Yuan, C. Sun, H. Lee, and M. Yu Opposing effects of dietary n-3 and n-6 fatty acids on mammary carcinogenesis: the Singapore Chinese Health Study Br J Cancer 89 2003 1686 1692
17. P. Bougnoux, N. Hajjaji, K. Maheo, C. Couet, and S. Chevalier Fatty acids and breast cancer: sensitization to treatments and prevention of metastatic re-growth Prog Lipid Res 49 1 2010 76 86
18. H.J. Murff, X.O. Shu, and H. Li Dietary polyunsaturated fatty acids and breast cancer risk in Chinese women: a prospective cohort study Int J Cancer 128 6 2011 1434 1441
19. A.P. Simopoulos Essential fatty acids in health and chronic disease Am J Clin Nutr 70 3 1999 560s 569s
20. M. Kobayashi, Y. Tsubono, T. Otani, T. Hanaoka, T. Sobue, and S. Tsugane Fish, long-chain n-3 polyunsaturated fatty acids, and risk of colorectal cancer in middle-aged Japanese: the JPHC study Nutr Cancer 49 1 2004 32 40
21. I. Akedo, H. Ishikawa, and T. Nakamura Three cases with familial adenomatous polyposis diagnosed as having malignant lesions in the course of a long-term trial using docosahexanoic acid (DHA)-concentrated fish oil capsules Jap J Clin Oncol 28 12 1998 762 765
22. M.C. Stern, L.M. Butler, and R. Corral Polyunsaturated fatty acids, DNA repair single nucleotide polymorphisms and colorectal cancer in the Singapore Chinese Health Study J Nutrigenet Nutrigenomics 2 6 2009 273 279
23. M.L. Nording, J. Yang, and K. Georgi Individual variation in lipidomic profiles of healthy subjects in response to omega-3 fatty acids PLOS ONE 8 10 2013 e76575
24. A.P. Simopoulos Genetic variants in the metabolism of omega-6 and omega-3 fatty acids: their role in the determination of nutritional requirements and chronic disease risk Exp Biol Med (Maywood) 235 7 2010 785 795
25. C.B. Stephensen, P. Armstrong, and J.W. Newman ALOX5 gene variants affect eicosanoid production and response to fish oil supplementation J Lipid Res 52 5 2011 991 1003
26. I. Rudkowska, A.-M. Paradis, and E. Thifault Differences in metabolomic and transcriptomic profiles between responders and non-responders to an n-3 polyunsaturated fatty acids (PUFAs) supplementation Genes Nutr 8 4 2013 411 423
27. P. Yang, Y. Jiang, and S.M. Fischer Prostaglandin E3 metabolism and cancer Cancer Lett 348 2014 1 11
28. P. Sapieha, A. Stahl, and J. Chen 5-Lipoxygenase metabolite 4-HDHA is a mediator of the antiangiogenic effect of omega-3 polyunsaturated fatty acids Sci Transl Med 3 69 2011 69ra12
29. G. Zhang, D. Panigrahy, and L.M. Mahakian Epoxy metabolites of docosahexaenoic acid (DHA) inhibit angiogenesis, tumor growth, and metastasis Proc Natl Acad Sci U S A 110 16 2013 6530 6535
30. C.N. Serhan Novel lipid mediators and resolution mechanisms in acute inflammation: to resolve or not? Am J Pathol 177 4 2010 1576 1591
31. C.N. Serhan, and N.A. Petasis Resolvins and protectins in inflammation resolution Chem Rev 111 10 2011 5922 5943
32. C.N. Serhan Pro-resolving lipid mediators are leads for resolution physiology Nature 510 7503 2014 92 101
33. C.D. Funk Prostaglandins and leukotrienes: advances in eicosanoid biology Science 294 5548 2001 1871 1875
34. D. Wang, and R.N. Dubois Eicosanoids and cancer Nat Rev Cancer 10 3 2010 181 193
35. D. Panigrahy, A. Kaipainen, E.R. Greene, and S. Huang Cytochrome P450-derived eicosanoids: the neglected pathway in cancer Cancer Metastasis Rev 29 4 2010 723 735
36. D. Panigrahy, E.R. Greene, A. Pozzi, D.W. Wang, and D.C. Zeldin EET signaling in cancer Cancer Metastasis Rev 30 3-4 2011 525 540
37. L.M. Arterburn, E.B. Hall, and H. Oken Distribution, interconversion, and dose response of n-3 fatty acids in humans Am J Clin Nutr 83 6 Suppl. 2006 76S 1467S
38. M.C. Pender-Cudlip, K.J. Krag, and D. Martini Delta-6-desaturase activity and arachidonic acid synthesis are increased in human breast cancer tissue Cancer Sci 104 6 2013 760 764
39. J.R. Graff, B.W. Konicek, and J.A. Deddens Expression of group IIa secretory phospholipase A2 increases with prostate tumor grade Clin Cancer Res 7 12 2001 3857 3861
40. D.P. Rose, and J.M. Connolly Omega-3 fatty acids as cancer chemopreventive agents Pharmacol Ther 83 3 1999 217 244
41. D.C. Farrow, T.L. Vaughan, and P.D. Hansten Use of aspirin and other nonsteroidal anti-inflammatory drugs and risk of esophageal and gastric cancer Cancer Epidemiol Biomarkers Prev 7 2 1998 97 102
42. R.A. Gupta, and R.N. DuBois Colorectal cancer prevention and treatment by inhibition of cyclooxygenase-2 Nat Rev Cancer 1 1 2001 11 21
43. R.S. Bresalier, R.S. Sandler, and H. Quan Cardiovascular events associated with rofecoxib in a colorectal adenoma chemoprevention trial N Engl J Med 352 11 2005 1092 1102
44. G.A. FitzGerald Coxibs and cardiovascular disease N Engl J Med 351 17 2004 1709 1711
45. M. Hedelin, E.T. Chang, and F. Wiklund Association of frequent consumption of fatty fish with prostate cancer risk is modified by COX-2 polymorphism Int J Cancer 120 2 2007 398 405
46. V. Fradet, I. Cheng, G. Casey, and J.S. Witte Dietary omega-3 fatty acids, cyclooxygenase-2 genetic variation, and aggressive prostate cancer risk Clin Cancer Res 15 7 2009 2559 2566
47. A.L. Groeger, C. Cipollina, and M.P. Cole Cyclooxygenase-2 generates anti-inflammatory mediators from omega-3 fatty acids Nat Chem Biol 6 6 2010 433 441
48. M.G. Malkowski, E.D. Thuresson, and K.M. Lakkides Structure of eicosapentaenoic and linoleic acids in the cyclooxygenase site of prostaglandin endoperoxide H synthase-1 J Biol Chem 276 40 2001 37547 37555
49. O. Laneuville, D.K. Breuer, and N. Xu Fatty acid substrate specificities of human prostaglandin-endoperoxide H synthase-1 and -2: formation of 12-hydroxy-(9Z,13E/Z,15Z)-octadecatrienoic acids from α-linolenic acid J Bio Chem 270 33 1995 19330 19336
50. D. Bagga, L. Wang, R. Farias-Eisner, J.A. Glaspy, and S.T. Reddy Differential effects of prostaglandin derived from omega-6 and omega-3 polyunsaturated fatty acids on COX-2 expression and IL-6 secretion Proc Natl Acad Sci U S A 100 4 2003 1751 1756
51. M. Szymczak, M. Murray, and N. Petrovic Modulation of angiogenesis by omega-3 polyunsaturated fatty acids is mediated by cyclooxygenases Blood 111 7 2008 3514 3521
52. P. Yang, D. Chan, and E. Felix Formation and antiproliferative effect of prostaglandin E(3) from eicosapentaenoic acid in human lung cancer cells J Lipid Res 45 6 2004 1030 1039
53. S. Xia, Y. Lu, and J. Wang Melanoma growth is reduced in fat-1 transgenic mice: impact of omega-6/omega-3 essential fatty acids Proc Natl Acad Sci U S A 103 33 2006 12499 12504
54. Y. Denkins, D. Kempf, M. Ferniz, S. Nileshwar, and D. Marchetti Role of omega-3 polyunsaturated fatty acids on cyclooxygenase-2 metabolism in brain-metastatic melanoma J Lipid Res 46 6 2005 1278 1284
55. G. Hawcroft, P.M. Loadman, A. Belluzzi, and M.A. Hull Effect of eicosapentaenoic acid on E-type prostaglandin synthesis and EP4 receptor signaling in human colorectal cancer cells Neoplasia 12 8 2010 618 627
56. S. Hegde, N. Kaushal, and K.C. Ravindra Δ12-Prostaglandin J3, an omega-3 fatty acid-derived metabolite, selectively ablates leukemia stem cells in mice Blood 118 26 2011 6909 6919
57. S. Il Lee, X. Zuo, and I. Shureiqi 15-Lipoxygenase-1 as a tumor suppressor gene in colon cancer: is the verdict in? Cancer Metastasis Rev 30 3-4 2011 481 491
58. M.C. Cathcart, J. Lysaght, and G.P. Pidgeon Eicosanoid signalling pathways in the development and progression of colorectal cancer: novel approaches for prevention/intervention Cancer Metastasis Rev 30 3-4 2011 363 385
59. F. Cianchi, C. Cortesini, and L. Magnelli Inhibition of 5-lipoxygenase by MK886 augments the antitumor activity of celecoxib in human colon cancer cells Mol Cancer Ther 5 11 2006 2716 2726
60. J. Martel-Pelletier, D. Lajeunesse, P. Reboul, and J.P. Pelletier Therapeutic role of dual inhibitors of 5-LOX and COX, selective and non-selective non-steroidal anti-inflammatory drugs Ann Rheum Dis 62 6 2003 501 509
61. K.M. Connor, J.P. SanGiovanni, and C. Lofqvist Increased dietary intake of omega-3-polyunsaturated fatty acids reduces pathological retinal angiogenesis Nat Med 13 7 2007 868 873
62. C. Miller, R.Y. Yamaguchi, and V.A. Ziboh Guinea pig epidermis generates putative anti-inflammatory metabolites from fish oil polyunsaturated fatty acids Lipids 24 12 1989 998 1003
63. H.Y. Kim, J.W. Karanian, and N. Salem Jr. Formation of 15-lipoxygenase product from docosahexaenoic acid (22:6w3) by human platelets Prostaglandins 40 5 1990 539 549
64. V.A. Ziboh, C.C. Miller, and Y. Cho Metabolism of polyunsaturated fatty acids by skin epidermal enzymes: generation of antiinflammatory and antiproliferative metabolites Am J Clin Nutr 71 1 Suppl. 2000 361s 366s
65. A.F. Bento, R.F. Claudino, R.C. Dutra, R. Marcon, and J.B. Calixto Omega-3 fatty acid-derived mediators 17(R)-hydroxy docosahexaenoic acid, aspirin-triggered resolvin D1 and resolvin D2 prevent experimental colitis in mice J Immunol 187 4 2011 1957 1969
66. C.Y. Chiu, B. Gomolka, and C. Dierkes Omega-6 docosapentaenoic acid-derived resolvins and 17-hydroxydocosahexaenoic acid modulate macrophage function and alleviate experimental colitis Inflamm Res 61 9 2012 967 976
67. K. Vang, and V.A. Ziboh 15-Lipoxygenase metabolites of gamma-linolenic acid/eicosapentaenoic acid suppress growth and arachidonic acid metabolism in human prostatic adenocarcinoma cells: possible implications of dietary fatty acids Prostaglandins Leukot Essent Fatty Acids 72 5 2005 363 372
68. J.T. O'Flaherty, Y. Hu, and R.E. Wooten 15-Lipoxygenase metabolites of docosahexaenoic acid inhibit prostate cancer cell proliferation and survival PLOS ONE 7 9 2012 e45480
69. Y. Hu, H. Sun, J.T. O'Flaherty, and I.J. Edwards 15-Lipoxygenase-1-mediated metabolism of docosahexaenoic acid is required for syndecan-1 signaling and apoptosis in prostate cancer cells Carcinogenesis 34 1 2013 176 182
70. H. Gleissman, R. Yang, and K. Martinod Docosahexaenoic acid metabolome in neural tumors: identification of cytotoxic intermediates Faseb J 24 3 2010 906 915
71. J.H. Dwyer, H. Allayee, and K.M. Dwyer Arachidonate 5-lipoxygenase promoter genotype, dietary arachidonic acid, and atherosclerosis N Engl J Med 350 1 2004 29 37
72. G. Zhang, S. Kodani, and B.D. Hammock Stabilized epoxygenated fatty acids regulate inflammation, pain, angiogenesis and cancer Prog Lipid Res 53 0 2014 108 123
73. D.L. Kroetz, and F. Xu Regulation and inhibition of arachidonic acid omega-hydroxylases and 20-HETE formation Annu Rev Pharmacol Toxicol 45 2005 413 438
74. D. Panigrahy, B.T. Kalish, and S. Huang Epoxyeicosanoids promote organ and tissue regeneration Proc Natl Acad Sci U S A 110 33 2013 13528 13533
75. D. Panigrahy, M.L. Edin, and C.R. Lee Epoxyeicosanoids stimulate multiorgan metastasis and tumor dormancy escape in mice J Clin Invest 122 1 2012 178 191
76. W. Zhang, J. Liao, and H. Li Reduction of inflammatory bowel disease-induced tumor development in IL-10 knockout mice with soluble epoxide hydrolase gene deficiency Mol Carcinog 52 9 2013 726 738
77. (-/-) mice Dig Dis Sci 57 10 2012 2580 2591
78. C. Arnold, M. Markovic, and K. Blossey Arachidonic acid-metabolizing cytochrome P450 enzymes are targets of {omega}-3 fatty acids J Biol Chem 285 43 2010 32720 32733
79. D. Lucas, S. Goulitquer, and J. Marienhagen Stereoselective epoxidation of the last double bond of polyunsaturated fatty acids by human cytochromes P450 J Lipid Res 51 5 2010 1125 1133
80. D. Schwarz, P. Kisselev, and S.S. Ericksen Arachidonic and eicosapentaenoic acid metabolism by human CYP1A1: highly stereoselective formation of 17(R),18(S)-epoxyeicosatetraenoic acid Biochem Pharmacol 67 8 2004 1445 1457
81. E. Barbosa-Sicard, M. Markovic, H. Honeck, B. Christ, D.N. Muller, and W.H. Schunck Eicosapentaenoic acid metabolism by cytochrome P450 enzymes of the CYP2C subfamily Biochem Biophys Res Commun 329 4 2005 1275 1281
82. C. Morisseau, B. Inceoglu, and K. Schmelzer Naturally occurring monoepoxides of eicosapentaenoic acid and docosahexaenoic acid are bioactive antihyperalgesic lipids J Lipid Res 51 12 2010 3481 3490
83. G.C. Shearer, W.S. Harris, T.L. Pedersen, and J.W. Newman Detection of omega-3 oxylipins in human plasma and response to treatment with omega-3 acid ethyl esters J Lipid Res 51 8 2010 2074 2081
84. A.H. Keenan, T.L. Pedersen, K. Fillaus, M.K. Larson, G.C. Shearer, and J.W. Newman Basal omega-3 fatty acid status affects fatty acid and oxylipin responses to high-dose n3-HUFA in healthy volunteers J Lipid Res 53 8 2012 1662 1669
85. A. Zivkovic, J. Yang, and K. Georgi Serum oxylipin profiles in IgA nephropathy patients reflect kidney functional alterations Metabolomics 8 6 2012 1102 1113
86. J.P. Schuchardt, S. Schmidt, and G. Kressel Modulation of blood oxylipin levels by long-chain omega-3 fatty acid supplementation in hyper- and normolipidemic men Prostaglandins Leukot Essent Fatty Acids 90 2-3 2014 27 37
87. R. Fischer, A. Konkel, and H. Mehling Dietary omega-3 fatty acids modulate the eicosanoid profile in man primarily via the CYP-epoxygenase pathway J Lipid Res 55 2014 1150 1164
88. C. Morin, M. Sirois, V. Echave, M.M. Gomes, and E. Rousseau EET displays anti-inflammatory effects in TNF-alpha stimulated human bronchi: putative role of CPI-17 Am J Respir Cell Mol Biol 38 2 2008 192 201
89. C. Morin, M. Sirois, V. Echave, R. Albadine, and E. Rousseau 17,18-Epoxyeicosatetraenoic acid targets PPARgamma and p38 mitogen-activated protein kinase to mediate its anti-inflammatory effects in the lung: role of soluble epoxide hydrolase Am J Respir Cell Mol Biol 43 5 2010 564 575
90. T. Kubota, M. Arita, and Y. Isobe Eicosapentaenoic acid is converted via omega-3 epoxygenation to the anti-inflammatory metabolite 12-hydroxy-17,18-epoxyeicosatetraenoic acid FASEB J 28 2 2014 586 593
91. D. Ye, D. Zhang, C. Oltman, K. Dellsperger, H.C. Lee, and M. VanRollins Cytochrome p-450 epoxygenase metabolites of docosahexaenoate potently dilate coronary arterioles by activating large-conductance calcium-activated potassium channels J Pharmacol Exp Ther 303 2 2002 768 776
92. A. Ulu, K.S. Stephen Lee, and C. Miyabe An omega-3 epoxide of docosahexaenoic acid lowers blood pressure in angiotensin-II dependent hypertension J Cardiovasc Pharmacol 64 2014 87 99
93. L.N. Agbor, M.T. Walsh, J.R. Boberg, and M.K. Walker Elevated blood pressure in cytochrome P4501A1 knockout mice is associated with reduced vasodilation to omega-3 polyunsaturated fatty acids Toxicol Appl Pharmacol 264 3 2012 351 360
94. P.H. Cui, N. Petrovic, and M. Murray The omega-3 epoxide of eicosapentaenoic acid inhibits endothelial cell proliferation by p38 MAP kinase activation and cyclin D1/CDK4 down-regulation Br J Pharmacol 162 5 2011 1143 1155
95. C.L. Chaffer, and R.A. Weinberg A perspective on cancer cell metastasis Science 331 6024 2011 1559 1564
96. J. Hu, R. Popp, and T. Fromel Muller glia cells regulate Notch signaling and retinal angiogenesis via the generation of 19,20-dihydroxydocosapentaenoic acid J Exp Med 211 2 2014 281 295
97. Z. Shao, Z. Fu, and A. Stahl Cytochrome P450 2C8 omega3-long-chain polyunsaturated fatty acid metabolites increase mouse retinal pathologic neovascularization - brief report Arterioscler Thromb Vasc Biol 34 3 2014 581 586
98. J. Yang, K. Schmelzer, K. Georgi, and B.D. Hammock Quantitative profiling method for oxylipin metabolome by liquid chromatography electrospray ionization tandem mass spectrometry Anal Chem 81 19 2009 8085 8093
99. K. Schmelzer, E. Fahy, S. Subramaniam, and E.A. Dennis The lipid maps initiative in lipidomics Methods Enzymol 432 2007 171 183
100. S.H. Zeisel, R.A. Waterland, J.M. Ordovas, D.M. Muoio, W. Jia, and A. Fodor Highlights of the 2012 research workshop: using nutrigenomics and metabolomics in clinical nutrition research JPEN J Parenter Enteral Nutr 37 2 2013 190 200